Vurdering av GORE® SYNECOR biomateriale i fokuserte pasientpopulasjoner og langsiktig bruk (SYN 20-01)
The SYN 20-01 Study is a non-interventional, prospective, multicenter, multicohort, international, post-market clinical investigation looking into the assessment of GORE® SYNECOR Biomaterial in focused patient populations and in long-term application.
Patients with ventral / incisional hernia amenable to hernia mesh repair will be enrolled into two cohorts (US and EU cohort) and followed-up over the period of 60 months.
Studieoversikt
Status
Intervensjon / Behandling
Studietype
Registrering (Antatt)
Kontakter og plasseringer
Studiesteder
-
-
Georgia
-
Atlanta, Georgia, Forente stater, 30342
- Emory Saint Joseph's Hospital
-
-
Massachusetts
-
Boston, Massachusetts, Forente stater, 02111
- Tufts Medical Center
-
-
Michigan
-
Grand Rapids, Michigan, Forente stater, 49506
- Corewell Health
-
-
New Mexico
-
Albuquerque, New Mexico, Forente stater, 87109
- Lovelace Women's Hospital
-
-
New York
-
Stony Brook, New York, Forente stater, 11794
- Stony Brook University Hospital
-
-
North Carolina
-
Wilmington, North Carolina, Forente stater, 28401
- Novant Health New Hanover Regional Medical Center
-
-
South Carolina
-
Greenville, South Carolina, Forente stater, 29605
- Prisma Health Greenville Memorial Hospital
-
-
Virginia
-
Mechanicsville, Virginia, Forente stater, 23116
- Bon Secours Memorial Regional Medical Center
-
-
-
-
-
Baggiovara, Italia, 41126
- Ospedale Civile di Baggiovara
-
Naples, Italia, 80131
- Vincenzo Monaldi Hospital
-
Roma, Italia, 00189
- Sapienza Università di Roma
-
-
-
-
-
Seville, Spania, 41009
- University Hospital Virgen Macarena - Department of General And Digestive Surgery
-
Seville, Spania, 41013
- Hospital Quirón Salud-Sagrado Corazón
-
-
-
-
-
Birmingham, Storbritannia, B15 2GW
- University Hospitals Birmingham NHS Foundation Trust - Queen Elizabeth Hospital Birmingham
-
Walsall, Storbritannia, WS2 9PS
- Walsall Manor Hospital
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Prøvetakingsmetode
Studiepopulasjon
The SYN 20-01 study population will consist of patients who present with ventral/incisional hernia disease requiring treatment per the evaluating physician. Eligible study subjects need to be amenable to treatment with a permanent synthetic mesh as suggested by the inclusion and exclusion criteria for each study cohort.
Beskrivelse
Key Inclusion Criteria - IP Cohort:
- De-Novo ventral/incisional hernia amenable to repair with GORE® SYNECOR IP Biomaterial
- Clean wound (CDC Wound Class I)
- mVHWG Grade 1 or 2 (modified Ventral Hernia Working Group)
Key Exclusion Criteria - IP Cohort:
- Wound is either clean-contaminated, contaminated or dirty-infected
Key Inclusion Criteria - PRE Cohort:
- De-novo ventral/incisional hernia, with subject anatomy and surgical plan amenable to open surgical repair or minimally invasive surgery with the GORE® SYNECOR PRE Biomaterial placed in a sublay fashion within the preperitoneal space
- Clean wound (CDC Wound Class I)
- mVHWG Grade 1 or 2 (modified Ventral Hernia Working Group)
Key Exclusion Criteria - PRE Cohort:
- Wound is either clean-contaminated, contaminated or dirty-infected
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Observasjonsmodeller: COHORT
- Tidsperspektiver: PROSPECTIVE
Kohorter og intervensjoner
Gruppe / Kohort |
Intervensjon / Behandling |
|---|---|
|
SYNECOR IP Device
Hernia mesh repair with GORE® SYNECOR Intraperitoneal Biomaterial |
Hernia repair with GORE® SYNECOR Biomaterial; technical approach laparoscopic, robotic or open surgical / minimally invasive surgery |
|
SYNECOR PRE Device
Hernia mesh repair with GORE® SYNECOR Preperitoneal Biomaterial |
Hernia repair with GORE® SYNECOR Biomaterial; technical approach laparoscopic, robotic or open surgical / minimally invasive surgery |
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Hernia Recurrence
Tidsramme: 24 Months
|
Hernia Recurrence Treated Location |
24 Months
|
|
Hernia Recurrence
Tidsramme: 60 Months
|
Hernia Recurrence Treated Location |
60 Months
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Hospital Re-Admission
Tidsramme: 60 Months
|
Device or procedural-related |
60 Months
|
|
Thirty-Day Mortality
Tidsramme: 30 Day
|
Mortality of all causes |
30 Day
|
|
SSO within 24 months post-procedure
Tidsramme: 24 Months
|
Surgical Site Occurrence (SSO) |
24 Months
|
|
SSI (Surgical Site Infection)
Tidsramme: 60 Months
|
Surgical Site Infection (SSI) |
60 Months
|
|
Freedom from mesh-involved events
Tidsramme: 60 Months
|
Freedom from mesh-involved events |
60 Months
|
|
Major Seroma (clinically confirmed)
Tidsramme: 60 Months
|
Major Seroma as clinically assessed (physiological parameters) and defined as seroma requiring treatment in the presence of infection, recurrence, mesh rejection or the need to be punctured/aspirated will be described without specific hypothesis or formal goal. Number of subjects with reported major seroma will be described as clinically confirmed by the investigator. |
60 Months
|
|
Change in Quality of Life (QoL) - SF 36 Questionnaire
Tidsramme: 60 Months
|
SF 36 Questionnaire (36-Item Short Form Survey Instrument; possible score ranges from 0 to 100 points. 0 points represent the greatest possible limitation of health, while 100 points represent the absence of health restrictions) |
60 Months
|
|
Change in Quality of Life (QoL) - Carolinas Comfort Scale (CCS)
Tidsramme: 60 Months
|
Carolinas Comfort Scale (CCS); CCS was designed that a lower score indicates a favorable health status; the total score is based on a scale of 0 - 115) |
60 Months
|
|
Ventral Hernia Recurrence Inventory sensitivity / specificity within 60 Month Follow-Up
Tidsramme: 60 Months
|
VHRI Survey (Ventral Hernia Recurrence Inventory) |
60 Months
|
|
Adverse Events by Clavien Dindo Classification
Tidsramme: 60 Months
|
Adverse Events by Clavien Dindo Classification |
60 Months
|
|
Surgical Site Occurrences (SSOPI) requiring Procedural Intervention
Tidsramme: 24 Months
|
Surgical Site Occurrences (SSOPI) requiring Procedural Intervention |
24 Months
|
|
Surgical Site Occurrences (SSOPI) requiring Procedural Intervention
Tidsramme: 60 Months
|
Surgical Site Occurrences (SSOPI) requiring Procedural Intervention |
60 Months
|
Samarbeidspartnere og etterforskere
Sponsor
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- SYN 20-01
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
produkt produsert i og eksportert fra USA
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .